# Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia

> **NCT07680803** · PHASE2 · RECRUITING · sponsor: **Fondazione Telethon** · enrollment: 9 (estimated)

## Conditions studied

- Transfusion-dependent Beta-Thalassemia

## Interventions

- **GENETIC:** FT007

## Key facts

- **NCT ID:** NCT07680803
- **Lead sponsor:** Fondazione Telethon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-06
- **Primary completion:** 2028-10
- **Final completion:** 2030-10
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680803, "Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07680803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*